Abbott India Limited (ABBOTINDIA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Abbott India Limited (ABBOTINDIA) has a cash flow conversion efficiency ratio of 0.130x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs5.22 Billion ≈ $56.45 Million USD) by net assets (Rs40.11 Billion ≈ $433.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Abbott India Limited to measure how many days the company can operate on defensive assets alone.
Abbott India Limited - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how Abbott India Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Abbott India Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Abbott India Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Eregli Demir ve Celik Fabrikalari TAS
IS:EREGL
|
-0.068x |
|
SmartSens Technology (Shanghai) Co. Ltd. A
SHG:688213
|
N/A |
|
PGE Polska Grupa Energetyczna SA
WAR:PGE
|
0.025x |
|
Xinjiang Daqo New Energy Co Ltd
SHG:688303
|
0.002x |
|
Nexans S.A.
PA:NEX
|
0.212x |
|
Ringkjoebing Landbobank A/S
CO:RILBA
|
0.002x |
|
Yunnan Wenshan Electric Power Co Ltd
SHG:600995
|
0.050x |
|
Gates Industrial Corporation plc
NYSE:GTES
|
0.073x |
Annual Cash Flow Conversion Efficiency for Abbott India Limited (2005–2025)
The table below shows the annual cash flow conversion efficiency of Abbott India Limited from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see Abbott India Limited market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs42.33 Billion ≈ $457.80 Million |
Rs10.12 Billion ≈ $109.43 Million |
0.239x | -27.10% |
| 2024-03-31 | Rs36.99 Billion ≈ $400.02 Million |
Rs12.13 Billion ≈ $131.16 Million |
0.328x | +17.02% |
| 2023-03-31 | Rs31.89 Billion ≈ $344.83 Million |
Rs8.93 Billion ≈ $96.62 Million |
0.280x | -16.63% |
| 2022-03-31 | Rs28.20 Billion ≈ $304.95 Million |
Rs9.48 Billion ≈ $102.49 Million |
0.336x | +20.33% |
| 2021-03-31 | Rs26.02 Billion ≈ $281.41 Million |
Rs7.27 Billion ≈ $78.59 Million |
0.279x | +8.47% |
| 2020-03-31 | Rs24.32 Billion ≈ $262.98 Million |
Rs6.26 Billion ≈ $67.71 Million |
0.257x | +3.61% |
| 2019-03-31 | Rs20.09 Billion ≈ $217.22 Million |
Rs4.99 Billion ≈ $53.98 Million |
0.248x | +175.47% |
| 2018-03-31 | Rs16.93 Billion ≈ $183.07 Million |
Rs1.53 Billion ≈ $16.51 Million |
0.090x | -59.27% |
| 2017-03-31 | Rs13.87 Billion ≈ $149.99 Million |
Rs3.07 Billion ≈ $33.22 Million |
0.222x | +6.50% |
| 2016-03-31 | Rs11.96 Billion ≈ $129.30 Million |
Rs2.49 Billion ≈ $26.89 Million |
0.208x | -9.21% |
| 2015-03-31 | Rs9.38 Billion ≈ $101.39 Million |
Rs2.15 Billion ≈ $23.23 Million |
0.229x | +53.60% |
| 2014-03-31 | Rs8.33 Billion ≈ $90.09 Million |
Rs1.24 Billion ≈ $13.44 Million |
0.149x | -4.81% |
| 2013-03-31 | Rs6.47 Billion ≈ $69.96 Million |
Rs1.01 Billion ≈ $10.96 Million |
0.157x | +254.26% |
| 2012-03-31 | Rs5.44 Billion ≈ $58.85 Million |
Rs240.66 Million ≈ $2.60 Million |
0.044x | -70.68% |
| 2011-03-31 | Rs3.05 Billion ≈ $33.03 Million |
Rs460.64 Million ≈ $4.98 Million |
0.151x | +10.24% |
| 2010-03-31 | Rs2.72 Billion ≈ $29.37 Million |
Rs371.57 Million ≈ $4.02 Million |
0.137x | -65.29% |
| 2009-03-31 | Rs2.21 Billion ≈ $23.93 Million |
Rs872.13 Million ≈ $9.43 Million |
0.394x | +196.26% |
| 2008-03-31 | Rs2.31 Billion ≈ $24.98 Million |
Rs307.40 Million ≈ $3.32 Million |
0.133x | -19.72% |
| 2007-03-31 | Rs2.46 Billion ≈ $26.58 Million |
Rs407.40 Million ≈ $4.41 Million |
0.166x | -2.57% |
| 2006-03-31 | Rs2.16 Billion ≈ $23.41 Million |
Rs368.20 Million ≈ $3.98 Million |
0.170x | -53.15% |
| 2005-03-31 | Rs1.88 Billion ≈ $20.36 Million |
Rs683.70 Million ≈ $7.39 Million |
0.363x | -- |
About Abbott India Limited
Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, … Read more